Molecular progression of SHH-activated medulloblastomas

Acta Neuropathol. 2019 Aug;138(2):327-330. doi: 10.1007/s00401-019-02022-y. Epub 2019 Apr 27.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Cerebellar Neoplasms / genetics*
  • Cerebellar Neoplasms / mortality
  • Cerebellar Neoplasms / pathology
  • Cerebellar Neoplasms / therapy
  • Child
  • Child, Preschool
  • Combined Modality Therapy
  • Cranial Irradiation
  • DNA, Neoplasm / genetics
  • Disease Progression
  • Gene Expression Regulation, Neoplastic
  • Hedgehog Proteins / physiology*
  • Humans
  • Infant
  • Medulloblastoma / genetics*
  • Medulloblastoma / mortality
  • Medulloblastoma / pathology
  • Medulloblastoma / therapy
  • Mutation
  • Neoplasm Metastasis
  • Neoplasm Proteins / genetics
  • Neoplasm Proteins / physiology*
  • Neoplasm Recurrence, Local / pathology
  • Neoplasm Recurrence, Local / surgery
  • Patched-1 Receptor / genetics
  • Patched-1 Receptor / physiology
  • Patched-2 Receptor
  • RNA, Messenger / genetics
  • RNA, Neoplasm / genetics
  • Young Adult

Substances

  • DNA, Neoplasm
  • Hedgehog Proteins
  • Neoplasm Proteins
  • PTCH1 protein, human
  • Patched-1 Receptor
  • Patched-2 Receptor
  • RNA, Messenger
  • RNA, Neoplasm
  • SHH protein, human